Disclosures for "Clinical and Radiographic Improvement in a Patient with Von Hippel-Lindau Disease-Associated Central Nervous System Hemangioblastoma Treated with Belzutifan"
-
Dr. Kim has nothing to disclose.
-
Dr. Lukas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck and Company, Inc.. Dr. Lukas has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck and Company, Inc.. Dr. Lukas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novocure. Dr. Lukas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO. Dr. Lukas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink Neurology. Dr. Lukas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Lukas has received research support from BMS. The institution of Dr. Lukas has received research support from BrainUp. The institution of Dr. Lukas has received research support from National Cancer Institute. The institution of Dr. Lukas has received research support from National Cancer Institute. The institution of Dr. Lukas has received research support from Ziopharm.
-
Dr. Dixit has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Servier.
-
Ms. Schwartz has received personal compensation in the range of $0-$499 for serving as a Consultant for EnCler Therapies. Ms. Schwartz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novocure.
-
Dr. Kumthekar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biocept. Dr. Kumthekar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Enclear. Dr. Kumthekar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Affinia Therapeutics. Dr. Kumthekar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Kumthekar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orbus Therapeutics. Dr. Kumthekar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bioclinica. Dr. Kumthekar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novocure. Dr. Kumthekar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Kumthekar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bioclinica. Dr. Kumthekar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier. Dr. Kumthekar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BPGbio. Dr. Kumthekar has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Seagen.